Skip to main content
. Author manuscript; available in PMC: 2021 Sep 7.
Published in final edited form as: Am J Hematol. 2019 Jul 29;94(10):1072–1080. doi: 10.1002/ajh.25575

TABLE 7.

Results of cox model for OS, RFS, Relapse, and NRM

OS RFS Relapse NRM
n HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
Acute GVHD*
 No acute GVHD 93 Reference Reference Reference Reference
 l-llaGVHD& Liver (−) 79 0.87 (0.57–1.33) 0.517 0.89 (0.59–1.36) 0.599 1.67 (0.82–3.41) 0.161 0.60 (0.35–1.04) 0.068
 l-llaGVHD& Liver (+) 14 1.12 (0.52–2.40) 0.778 1.09 (0.51–2.34) 0.819 0.45 (0.06–3.50) 0.444 1.37 (0.60–3.14) 0.459
 lll-IV aGVHD & Liver (−) 38 1.44 (0.87–2.40) 0.160 1.41 (0.85–2.33) 0.187 0.77 (0.22–2.73) 0.687 1.63 (0.93–2.85) 0.088
 lll-IV aGVHD & Liver (+) 25 5.26 (3.15–8.76) <0.001 5.10 (3.07–8.47) <0.001 0.88 (0.11–6.80) 0.901 6.57 (3.82–11.30) <0.001
 Contrast lll-IV aGVHD & Liver (+) vs lll-IV aGVHD & Liver (−) 3.65 (2.00–6.65) <0.001 3.62 (1.99–6.61) <0.001 1.14 (0.12–11.09) 0.910 4.03 (2.14–7.61) <0.001
Chronic GVHD*
 No chronic GVHD 73 Reference Reference Reference Reference
 cGVHD & Liver (−) 83 1.17 (0.63–2.18) 0.620 1.39 (0.76–2.57) 0.288 1.03 (0.37–2.84) 0.954 1.67 (0.77–3.63) 0.192
 cGVHD & Liver (+) 93 1.50 (0.78–2.88) 0.225 1.71 (0.89–3.27) 0.108 0.70 (0.22–2.26) 0.551 2.56 (1.14–5.73) 0.022
 Contrast
cGVHD & Liver (+) vs cGVHD & Liver (−)
1.28 (0.80–2.05) 0.303 1.22 (0.77–1.95) 0.395 0.68 (0.27–1.69) 0.405 1.53 (0.88–2.66) 0.135
 Contrast
III-IV aGVHD & Liver (+) and cGVHD & Liver (+) vs III-IV aGVHD & Liver (−) and cGVHD & Liver (−)
4.67 (2.15–10.13) <0.001 4.43 (2.05–9.60) <0.001 0.77 (0.07–9.16) 0.839 6.16 (2.62–14.49) <0.001